Member Info for notrac

Recent transaction for 21 million shares .

Travelling to Central Africa is expensive. These guys are not going to be slumming it like poor NGO folk in economy; they'll fly business. Internal flights if they exist are not cheap and generally infrequent. They probably have to get to the site by private jet. Nor will they be staying in some godforsaken fleabitten place (West African reference, Desmond De Silva's "Madam where are your mangoes?"); they will be staying in secure accommodation. Doing business in the two Congos is expensive and can be dangerous, although 900K is a lot for a company like AAOG.

@50pFlute. Negative. He was asked by TW of ************* and didn't deny. Filing of TR1s in a timely manner is unregulated but it is good that he is still in. Can we move on now?

I suspect Chris Oil sold on June 17th (in the mid 20s) at the time of the announcement and then in the placing bought back enough to get him back to 7%.

@globe
Have you considered GDX or GDXJ?

It's a small amount to raise so it looks as though someone wanted in. Funds could be useful if Raithlin have funding issues.

Eco tipped by a ************* writer (not TW).

And they didn't know this yesterday or on Wednesday. Give me a break.
It still leaves me confused on the matter of efficacy.

Chief Executive stays on. Damage to revenues and profit calculated. Should be positive.

Rig mobilised.

For the avoidance of doubt.

The notes to the financial statements "Cash and cash equivalents at 31 December 2018 amounted to GBP4.9 million (2017: GBP2.7 million). Financial borrowings were GBP121k (2017: GBP260k). This balance is primarily the conditional advance from the French Government for use in the development of our cancer program. No interest is payable. In January 2018, ImmuPharma successfully completed a share placing raising GBP10 million before expenses."

"In September 2018, the Company invested GBP2.0 million (2017: GBPnil) in Incanthera Limited (Incanthera) with whom it also entered discussions on a potential collaboration on the Nucant program. The Company purchased 363,637 shares in Incanthera at a price of GBP5.50 per share. This represents a holding of approximately 15% in Incanthera. The Company was also granted warrants for a further 363,637 shares at GBP5.50 per share."

The 2 million investment in Incanthera is reported in the balance sheet as a non-currrent asset which means that it is not expected to be realised within the next twelve months. It is separate from the cash.

LO may have made a nice profit on the investment since December but like those of us who have been here sometime they bought large chunks of shares north of 50p. I maintain a spreadsheet of their purchases and disposals and they are just about even (the net cost of their current holding is pretty close to 25p).
Management bonuses are out of order.
Payment to Derek Martin was probably necessary. It makes it look as if FUM let him go but I think it was the other way round. I think he lost patience.

The problem for MFTB is that if they need to do further work, they will need to raise funds. To some of doomsters here, the cash position in IMM may be dwindling but there is no immediate or short-term need to raise funds.

Another 2 million shares sold into strength last week.

For the bid to succeed, BVS would have to offer a cash element. I am surprised that they divulged so much detail about the proposed offer, They could have said negotiations took place but have now finished without going into details. This must be a carrot to GRFD's institutional shareholders to think again but GFRD without LInden Homes is not very exciting proposition.

They need corporate finance advice rather than someone to place their stock.

Genuinely sorry to read all this. After Badile in 2017 Idecided to bail out. JP's flashy cufflinks, presentation style, and the cornerstone investor were negatives I also wasn't happy with the unexplained departure of the then finance officer in early 2017.

LDOH or bad news from the Eastern Front?

Nudging 100p and tight spread.

There have been two RNS since close last night. Blackrock have, I suspect, sold their entire 5.33% stake. The new shareholder (unkown to me) has a 12% stake. Another institution must have sold so another RNS awaited.